Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.

"Competing interests The authors declare no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China (Grant numbers 81870365, 82070512, 82270529), and the Natural Science Foundation of Young (No. 81900450)]."

"We designed this study in accordance with the checklist for critical appraisal and data extraction for systematic reviews of prediction modeling studies (CHARMS) and used the PROBAST to assess the ROB of the studies. We presented this study in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). This protocol was registered on PROSPERO (Prospero registration number: CRD42022312740), We used published articles from open access databases, so specific patient consent and ethics committee’s approval were not required."